StemCells Inc - STEM - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 12, 2013

StemCells Inc - SIC # 2836

Ticker	Exchange	SIC #	Website	Latest Ticker
STEM	Nasdaq	2836	http://www.stemcellsinc.com	1.93 +0.06
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for StemCells Inc STEMCELLS INC Financials - May 17th, 2013 11:04 am STEMCELLS INC Files SEC form 10-Q, Quarterly Report - May 9th, 2013 9:04 pm StemCells, Inc. Earnings Call scheduled for 4:30 pm ET today - May 9th, 2013 2:30 pm StemCells, Inc. Reports First Quarter 2013 Financial Results and Provides Business Update - May 9th, 2013 2:05 pm STEMCELLS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits - May 9th, 2013 7:11 am StemCells, Inc. Announces Webcast to Discuss First Quarter 2013 Financial Results and Business Update - May 7th, 2013 7:00 am StemCells Inc: CEO Martin McGlynn Is Building A Blockbuster Company - May 2nd, 2013 6:11 am StemCells, Inc. Adds Byers Eye Institute at Stanford as Second Site for Phase I/II Clinical Trial in Dry Age-Related Macular Degeneration - Apr 18th, 2013 8:15 am StemCells, Inc. Adds Byers Eye Institute at Stanford as Second Site for Phase I/II Clinical Trial in Dry Age-Related Macular Degeneration - Apr 18th, 2013 7:00 am Investing In The Stem Cell Sector: An Overview - Apr 17th, 2013 6:36 am StemCells, Inc. to Participate at 2013 Regen Med Investor Day in New York - Apr 15th, 2013 8:06 am StemCells, Inc. to Participate at 2013 Regen Med Investor Day in New York - Apr 15th, 2013 7:00 am 3 Healthcare Stock Stories for Thursday Enjoyment - Apr 11th, 2013 3:51 pm StemCells, Inc. Enters Agreement to Receive $19.3 Million From California Institute for Regenerative Medicine to Help Fund IND for Alzheimer's Disease - Apr 11th, 2013 7:00 am STEMCELLS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligati - Apr 11th, 2013 12:11 am 4 Healthcare Stock Stories for Midweek Investment Wellness - Apr 10th, 2013 11:09 am CORRECTION -- StemCells, Inc. Closes $10 Million Debt Financing - Apr 9th, 2013 2:18 pm StemCells closes $10M debt financing - Apr 9th, 2013 7:14 am StemCells, Inc. Closes $10 Million Debt Financing - Apr 9th, 2013 7:00 am Over $400 Million Raised by U.S. Life Sciences Companies Through At-the-Market (ATM) Offerings in 2012, Reports Brinson Patrick - Apr 8th, 2013 6:00 am View All Current Headlines >>